Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: Implications for radiation carcinogenesis

Radiation Research

Volumn 146, Issue 1, 1996, Pages 43-52

  Kyoizumi, Seishi ^a   Akiyama, Mitoshi ^a   Cologne, John B ^a   Tanabe, Kazumi ^a   Nakamura, Nori ^a   Awa, Akio A ^a   Hirai, Yuko ^a   Kusunoki, Yoichiro ^a   Umeki, Shigeko ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN A;

ADULT; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER RISK; CELL MUTANT; CIGARETTE SMOKING; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE LOCUS; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIATION RESPONSE; SOLID TUMOR; SOMATIC MUTATION;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; ERYTHROCYTES; FEMALE; GLYCOPHORIN; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RADIATION DOSAGE; REPRODUCIBILITY OF RESULTS;

EID: 0029957134     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579394     Document Type: Article

References (49)

1. J. M. Bishop, Molecular themes in oncogenesis. Cell 64, 235-248 (1991).
2. F. P. Perera and R. M. Whyatt, Biomarkers and molecular epidemiology in mutation/cancer research. Mutat. Res. 313, 117-129 (1994).
3. J. Cole and J. R. Skopek, Somatic mutant frequency, mutation rates and mutation spectra in the human population in vivo. Mutat. Res. 304, 33-105 (1994).
4. R. C. Langlois, W. L. Bigbee and R. H. Jensen, Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Hum. Genet. 74, 353-362 (1986).
5. S. Kyoizumi, N. Nakamura, M, Hakoda, A. A. Awa, M. A. Bean, R. H. Jensen and M. Akiyama, Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res. 49, 581-588 (1989).
6. R. J. Albertini, K. L. Castle and W. R. Borchering, T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. USA 79, 6617-6621 (1982).
7. A. A. Morley, K. J. Trainor, R. Seshadri and R. C. Ryall, Measurement of in vivo mutations in human lymphocytes. Nature 302, 155-156 (1983).
8. M. Janatipour, K. J. Trainor, R. Kutlaca, C. Bennett, J. Hay, D. R. Turner and A. A. Morley, Mutations in human lymphocytes studied by an HLA selection system. Mutat. Res. 198, 221-226 (1988).
9. J. Kushiro, Y. Hirai, Y. Kusunoki, S. Kyoizumi, Y. Kodama, A. Wakisaka, A. Jeffereys, J. B. Cologne, K. Dohi, N. Nakamura and M. Akiyama, Development of a flow-cytometric HLA-A locus mutation assay for human peripheral blood lymphocytes. Mutat. Res. 272, 17-29 (1992).
10. + T cells. J. Exp. Med. 71, 1981-1999 (1990).
11. R. C. Langlois, W. L. Bigbee, S. Kyoizumi, N. Nakamura, M. A. Bean, M. Akiyama and R. H. Jensen, Evidence for increased somatic mutations at the glycophorin A locus in atomic bomb survivors. Science 236, 445-448 (1987).
12. D. E. Thompson, K. Mabuchi, M. Soda, E. Ron, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, S. Izumi and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137, S17-S67 (1994).
13. M. Akiyama, S. Umeki, Y. Kusunoki, S. Kyoizumi, N. Nakamura, T. Mori, Y. Ishikawa, M. Yamakido, K. Ohama, T. Kodama, K. Endo and J. B. Cologne, Somatic-cell mutations as a possible predictor of cancer risk. Health Phys. 68, 643-649 (1995).
14. A. A. Awa, Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki. J. Radiat. Res. 32 (Suppl.), 265-274 (1991).
15. R. Sposto, D. O. Stram and A. A. Awa, An estimate of the magnitude of random errors in the DS86 dosimetry from data on chromosome aberrations and severe epilation. Radiat. Res. 128, 157-169 (1991).
16. K. Mabuchi, M. Soda, E. Ron, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, D. L. Preston and D. E. Thompson, Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat. Res. 137, S1-S16 (1994).
17. W. C. Roesch, Ed., U.S.-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki, Final Report, Vols. 1 and 2. Radiation Effects Research Foundation. Hiroshima, 1987.
18. D. A. Pierce, D. O. Stram and M. Vaeth, Allowing for random errors in radiation exposure estimates for the atomic bomb survivor data. Radiat. Res. 123, 275-284 (1990).
19. K. Y. Liang and S. L. Zeger, Longitudinal data analysis using generalized linear models. Biometrika 73, 13-22 (1986).
20. A. Potnitzky and N. P. Jewell, Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika 77, 485-497 (1990).
21. R. Sposto, D. O. Stram and A. A. Awa. An Investigation of Random Errors in the DS86 Dosimetry Using Data on Chromosome Aberrations and Severe Epilation. TR 7-90, Radiation Effects Research Foundation, Hiroshima, 1990.
22. A. Knudson, Genetic events in human carcinogenesis. In Origin of Human Cancer: Comprehensive Review (J. Brugge, T. Carran, E. D. Harlow and F, McCormick, Eds.), pp. 17-25. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1991.
23. W. L. Bigbee, R. G. Langlois, M. Swift and R. H. Jensen, Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am. J. Hum. Genet. 44, 402-408 (1989).
24. S. Kyoizumi, N. Nakamura, H. Takebe, K. Tatsumi, J. German and M. Akiyama, Frequency of variant erythrocytes at the glycophorinA locus in two Bloom's syndrome patients. Mutat. Res. 214, 215-222 (1989).
25. R. G. Langlois, W. L. Bigbee, R. H. Jensen and J. German, Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Proc. Natl. Acad. Sci. USA 86, 670-674 (1989).
26. M. Sola-Trepat, J. Boyse, P. Richard, D. Papadopoulo and E. Moustacchi, Frequencies of HPRT-Iymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors. Mutat. Res. 289, 115-126 (1993).
27. L. Hagmar, A. Brogger, I-L. Hansteen, S. Heim, B. Högstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelam, I. Nordenson, C. Renterwall, S. Salomaa, S. Skerfving and M. Sorsa, Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 54, 2919-2922 (1994).
28. R. N. Buick and I. F. Tannock, Properties of malignant cells. In The Basic Science of Oncology (I. F. Tannock and R. P. Hill, Eds.), pp. 127-139. Pergamon Press, New York, 1987.
29. C. Cotsarelis, F. T. Sun and R. M. Lavker, Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogeneis. Cell 61, 1329-1337 (1990).
30. J. E. Trosko, Does radiation cause cancer? RERF Update 4, 3-5 (1992).
31. K. S. Iwamoto, Y. Hirai, S. Umeki, Y. Kusunoki, S. Kyoizumi, T. Kodama, K. Ohama, N. Nakamura and M. Akiyama, A positive correlation between T-cell-receptor mutant frequencies and dicentric chromosome frequencies in lymphocytes from radiotherapy patients. J. Radiat. Res. 35, 92-103 (1994).
32. S. Kyoizumi, S. Umeki, M. Akiyama, Y. Hirai, Y. Kusunoki, N. Nakamura, K, Endoh, J. Konishi, M. S. Sasaki, T. Mori, S. Fujita and J. B. Cologne, Frequency of mutant T lymphocytes defective in the expression of the T-cell antigen receptor gene among radiation-exposed people. Mutat. Res. 265, 173-180 (1992).
33. M. Hakoda, M. Akiyama, S. Kyoizumi, A. A. Awa, M. Yamakido and M. Otake, Increased somatic cell mutant frequency in atomic bomb survivors. Mutat. Res. 201, 39-48 (1988).
34. Y. Hirai, Y. Kusunoki, S. Kyoizumi, A. A. Awa, D. J. Pawel, N. Nakamura and M. Akiyama, Mutant frequency at the HPRT locus in peripheral blood T lymphocytes of atomic bomb survivors. Mutat. Res. 329, 183-196 (1995).
35. M. Akiyama, S. Kyoizumi, Y. Hirai, Y. Kusunoki, K. S. Iwamoto and N. Nakamura, Mutation frequency in human blood cells increases with age. Mutat. Res. 338, 141-149 (1995).
36. Y. Shimizu, H. Kato and W. J. Schull, Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat. Res. 121, 120-141 (1990).
37. R. L. Prentice, Y. Yoshimoto and M. W. Mason, Cigarette smoking and radiation exposure in relation to cancer mortality, Hiroshima and Nagasaki. J. Natl. Cancer Inst. 70, 611-622 (1983).
38. J. V. Neel, C. Satoh, P. Smouse, J. Asakawa, N. Takahashi, K. Goriki, M. Fujita, T. Kageoka and R. Hazama, Protein variants in Hiroshima and Nagasaki: Tales of two cities. Am. J. Hum. Genet. 43, 870-893 (1988).
39. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsui, H. Nonaka, D. E. Thompson, M. Soda and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137, S68-S97 (1994).
40. D. A. Pierce and M. Vaeth, The shape of the cancer mortality dose-response curve for the A-bomb survivors. Radiat. Res. 126, 36-42 (1991).
41. Y. Shimizu, M. Kato, W. J. Schull and K. Mabuchi, Dose response analysis among atomic-bomb survivors exposed to low level radiation. In Low Dose Irradiation and Biological Defense Mechanisms (T. Sugawara, L. A. Sagan and T. Aoyama, Eds.), pp. 71-74. Elsevier Science Publishers BV, Amsterdam, 1992.
42. M. L. Mendelsohn, Simple Reductionist Model for Cancer Risk in Atomic Bomb Survivors, pp. 1-8. CR 1-96, Radiation Effects Research Foundation, Hiroshima, 1996.
43. R. Peto, F. J. C. Roe, P. N. Lee, L. Levy and J. Clack, Cancer and ageing in mice and men. Br. J. Cancer 32, 411-426 (1975).
44. W. L. Bigbee, A. W. Wyrobek, R. C. Langlois, R. H. Jensen and R. B. Everson, The effect of chemotherapy on the in vivo frequency of glycophorin-A "null" variant erythrocytes. Mutat. Res. 240, 165-175 (1990).
45. M. Hewitt and M. G. Mott, The assessment of in vivo somatic mutations in survivors of childhood malignancy. Br. J. Cancer 66, 143-147 (1992).
46. H. Hirota, M. Kubota, S. Adachi, A. Okuda, Y. W. Lin, R. Bessho, Y. Wakazono, K. Matsubara, K. Kuwakado, Y. Akiyama and T. Tsutsui, Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: Comparison with HPRT locus mutation. Mutat. Res. 315, 95-103 (1994).
47. S. Jablon, Atomic Bomb Radiation Dose Estimation at ABCC. Atomic Bomb Casualty Commission, Hiroshima, 1971.
48. K. Neriishi, D. O. Stram, M. Vaeth, S. Mizuno and S. Akiba, The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors. Radiat. Res. 125, 206-213 (1991).
49. K. Neriishi, F. L. Wong, E. Nakashima, M. Otake, K. Kodama and K. Choshi, Relationship between cataract and epilation in atomic bomb survivors. Radiat. Res. 144, 107-113 (1995).